Lofibra 134 mg Gate 323 (Lofibra 134 mg)

Generic Name: fenofibrate

Pill with imprint Lofibra 134 mg Gate 323 is Blue, Capsule-shape and has been identified as Lofibra 134 mg. It is supplied by Gate Pharmaceuticals.

Lofibra is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia type v, elevated chylomicrons vldl; hyperlipoproteinemia type iv, elevated vldl and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Lofibra 134 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Lofibra 134 mg Gate 323

Lofibra

Generic Name:

fenofibrate

Imprint:

Lofibra 134 mg Gate 323

Strength:

134 mg

Color:

Blue

Size:

18.00 mm

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Fibric acid derivatives

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Labeler / Supplier:

Gate Pharmaceuticals

National Drug Code (NDC):

57844-0323

Inactive Ingredients:

• croscarmellose sodium
• lactose monohydrate
• magnesium stearate
• povidone k25
• corn starch
• sodium lauryl sulfate
• magnesium silicate
• D&C Red No. 28
• FD&C Blue No. 1
• titanium dioxide

Note: Inactive ingredients may vary.

More Info Imprint Search Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer